Published in PLoS One on April 25, 2014
Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity (2014) 7.26
Targeting GM-CSF in inflammatory diseases. Nat Rev Rheumatol (2015) 0.97
New therapeutic targets for cancer bone metastasis. Trends Pharmacol Sci (2015) 0.86
Physical and mechanical regulation of macrophage phenotype and function. Cell Mol Life Sci (2014) 0.82
Anti-tumor effect of a novel PI3-kinase inhibitor, SF1126, in (12) V-Ha-Ras transgenic mouse glioma model. Cancer Cell Int (2014) 0.81
Biological role of granulocyte macrophage colony-stimulating factor (GM-CSF) and macrophage colony-stimulating factor (M-CSF) on cells of the myeloid lineage. J Leukoc Biol (2016) 0.76
Rac2 Functions in Both Neutrophils and Macrophages To Mediate Motility and Host Defense in Larval Zebrafish. J Immunol (2016) 0.75
Identifying prognostic biomarkers based on aberrant DNA methylation in kidney renal clear cell carcinoma. Oncotarget (2016) 0.75
Eros is a novel transmembrane protein that controls the phagocyte respiratory burst and is essential for innate immunity. J Exp Med (2017) 0.75
MicroRNA-16 suppresses metastasis in an orthotopic, but not autochthonous, mouse model of soft tissue sarcoma. Dis Model Mech (2015) 0.75
Dual-activity PI3K-BRD4 inhibitor for the orthogonal inhibition of MYC to block tumor growth and metastasis. Proc Natl Acad Sci U S A (2017) 0.75
Hormetic Response to Low-Dose Radiation: Focus on the Immune System and Its Clinical Implications. Int J Mol Sci (2017) 0.75
Rac2 is required for alternative macrophage activation and bleomycin induced pulmonary fibrosis; a macrophage autonomous phenotype. PLoS One (2017) 0.75
Colony-stimulating factor-1-induced AIF1 expression in tumor-associated macrophages enhances the progression of hepatocellular carcinoma. Oncoimmunology (2017) 0.75
Immunomodulatory Monoclonal Antibodies in Combined Immunotherapy Trials for Cutaneous Melanoma. Front Immunol (2017) 0.75
Association of high microvessel αvβ3 and low PTEN with poor outcome in stage 3 neuroblastoma: rationale for using first in class dual PI3K/BRD4 inhibitor, SF1126. Oncotarget (2016) 0.75
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A (2005) 167.46
Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol (2004) 101.91
Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc (2008) 62.52
KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res (2011) 30.20
Exploring the full spectrum of macrophage activation. Nat Rev Immunol (2008) 26.08
Monocyte and macrophage heterogeneity. Nat Rev Immunol (2005) 24.36
Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics (2006) 22.61
The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol (2004) 19.38
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol (2002) 17.85
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature (1995) 15.15
Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer (2004) 14.55
Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol (2011) 12.21
Macrophages, inflammation, and insulin resistance. Annu Rev Physiol (2010) 11.77
Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature (1995) 9.84
Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol (2006) 9.82
A tense situation: forcing tumour progression. Nat Rev Cancer (2009) 7.80
Regulation of cell motility by mitogen-activated protein kinase. J Cell Biol (1997) 7.14
Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res (2006) 6.52
Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol (2011) 6.34
Inflammation meets cancer, with NF-κB as the matchmaker. Nat Immunol (2011) 6.17
The BioGRID interaction database: 2013 update. Nucleic Acids Res (2012) 6.09
Macrophage polarization comes of age. Immunity (2005) 5.67
Protein networks in disease. Genome Res (2008) 5.65
Immune and inflammatory mechanisms of atherosclerosis (*). Annu Rev Immunol (2009) 5.28
Inflammation, a key event in cancer development. Mol Cancer Res (2006) 5.03
Prioritizing candidate disease genes by network-based boosting of genome-wide association data. Genome Res (2011) 4.39
Integrins in angiogenesis and lymphangiogenesis. Nat Rev Cancer (2008) 4.27
Deficiency of the hematopoietic cell-specific Rho family GTPase Rac2 is characterized by abnormalities in neutrophil function and host defense. Immunity (1999) 3.84
Associating genes and protein complexes with disease via network propagation. PLoS Comput Biol (2010) 3.65
rac, a novel ras-related family of proteins that are botulinum toxin substrates. J Biol Chem (1989) 3.21
Determination of arginase activity in macrophages: a micromethod. J Immunol Methods (1994) 3.16
Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer. Dis Model Mech (2011) 2.97
Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation. J Immunol (2010) 2.88
Receptor tyrosine kinases and TLR/IL1Rs unexpectedly activate myeloid cell PI3kγ, a single convergent point promoting tumor inflammation and progression. Cancer Cell (2011) 2.70
Critical roles for Rac1 and Rac2 GTPases in B cell development and signaling. Science (2003) 2.46
Plasticity of macrophage function during tumor progression: regulation by distinct molecular mechanisms. J Immunol (2008) 2.26
Invasion of human breast cancer cells in vivo requires both paracrine and autocrine loops involving the colony-stimulating factor-1 receptor. Cancer Res (2009) 2.25
Untargeted metabolomic profiling as an evaluative tool of fenofibrate-induced toxicology in Fischer 344 male rats. Toxicol Pathol (2009) 2.16
Mammary epithelial cell: influence of extracellular matrix composition and organization during development and tumorigenesis. Int J Biochem Cell Biol (2007) 2.12
Integrin modulation and signaling in leukocyte adhesion and migration. Immunol Rev (2007) 2.10
The pathophysiologic role of alpha 4 integrins in vivo. J Clin Invest (1994) 2.07
Modeling metastasis in vivo. Carcinogenesis (2004) 2.02
GM-CSF- and M-CSF-dependent macrophage phenotypes display differential dependence on type I interferon signaling. J Leukoc Biol (2009) 2.00
Integrin signaling is critical for pathological angiogenesis. J Exp Med (2006) 1.91
Characterization of RAC3, a novel member of the Rho family. J Biol Chem (1997) 1.82
Intracellular signaling in M-CSF-induced microglia activation: role of Iba1. Glia (2002) 1.80
Rac and Cdc42 GTPases control hematopoietic stem cell shape, adhesion, migration, and mobilization. Proc Natl Acad Sci U S A (2001) 1.80
Role of the guanosine triphosphatase Rac2 in T helper 1 cell differentiation. Science (2000) 1.46
Rac2 is an essential regulator of neutrophil nicotinamide adenine dinucleotide phosphate oxidase activation in response to specific signaling pathways. J Immunol (2001) 1.41
Integrin alpha4beta1 promotes monocyte trafficking and angiogenesis in tumors. Cancer Res (2006) 1.41
Deficiency of small GTPase Rac2 affects T cell activation. J Exp Med (2001) 1.33
Rac GTPase interacts with GAPs and target proteins through multiple effector sites. EMBO J (1995) 1.25
Blocking the alpha 4 integrin-paxillin interaction selectively impairs mononuclear leukocyte recruitment to an inflammatory site. J Clin Invest (2006) 1.20
Protein networks as logic functions in development and cancer. PLoS Comput Biol (2011) 1.19
Anti-tumour synergy of cytotoxic chemotherapy and anti-CD40 plus CpG-ODN immunotherapy through repolarization of tumour-associated macrophages. Immunology (2010) 1.16
Expression of N-myc and MRP genes and their relationship to N-myc gene dosage and tumor formation in a murine neuroblastoma model. Med Pediatr Oncol (2000) 1.10
Vav activation and function as a rac guanine nucleotide exchange factor in macrophage colony-stimulating factor-induced macrophage chemotaxis. Mol Cell Biol (2005) 1.10
Rac2-deficient mice display perturbed T-cell distribution and chemotaxis, but only minor abnormalities in T(H)1 responses. Immunol Cell Biol (2002) 1.04
Rac2 specificity in macrophage integrin signaling: potential role for Syk kinase. J Biol Chem (2003) 1.01
Angiogenesis induced by tumor necrosis factor-agr; is mediated by alpha4 integrins. Angiogenesis (1998) 0.90
NeXO Web: the NeXO ontology database and visualization platform. Nucleic Acids Res (2013) 0.88
Rac2-deficiency leads to exacerbated and protracted colitis in response to Citrobacter rodentium infection. PLoS One (2013) 0.83
Expression of RAC2 in endothelial cells is required for the postnatal neovascular response. Exp Cell Res (2009) 0.83
M-CSF induces the stable interaction of cFms with alphaVbeta3 integrin in osteoclasts. Int J Biochem Cell Biol (2006) 0.80
Network approaches and applications in biology. PLoS Comput Biol (2017) 0.75